{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:34:52Z","timestamp":1778542492197,"version":"3.51.4"},"reference-count":30,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Advances in Endocrinology"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:p>Hypercalcaemia is commonly seen in the context of parathyroid dysfunction and malignancy and, when severe, can precipitate life-threatening sequelae. The differential of hypercalcaemia is broad and can be categorized based on parathyroid hormone (PTH) levels. The acute management of severe hypercalcaemia is discussed along with a brief review of therapeutic advances in the field.<\/jats:p>","DOI":"10.1177\/2042018810390260","type":"journal-article","created":{"date-parts":[[2010,12,13]],"date-time":"2010-12-13T11:43:44Z","timestamp":1292240624000},"page":"225-234","source":"Crossref","is-referenced-by-count":39,"title":["Review: Endocrine and metabolic emergencies: hypercalcaemia"],"prefix":"10.1177","volume":"1","author":[{"given":"Richard","family":"Carroll","sequence":"first","affiliation":[{"name":"Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Matfin","sequence":"additional","affiliation":[{"name":"Glenn Matfin, MSc (Oxon), MB ChB, FFPM, FACE, FACP, FRCP  Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA, Division of Endocrinology, New York University School of Medicine New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2010,12,13]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1080\/02841860310013111"},{"key":"atypb2","author":"Ayuk, J.","year":"2010","journal-title":"Ther Adv Endocrin Metab"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068157"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090810"},{"key":"atypb5","volume-title":"British National Formulary","author":"British National Formulary","year":"2010"},{"key":"atypb6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198809013190906"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2010.07.041"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1177\/2042018810366494"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-007-0490-1"},{"key":"atypb10","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph7052337"},{"key":"atypb11","doi-asserted-by":"publisher","DOI":"10.1097\/00130404-200601000-00009"},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2867-9-26"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2006.12.078"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra070553"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.4158\/EP.9.6.517"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4613"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-4-200808190-00007"},{"key":"atypb18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.558"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2640"},{"key":"atypb20","volume-title":"Disorders of fluid balance and electrolytes","author":"Matfin, G.","year":"2009","edition":"8"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.502"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.48"},{"key":"atypb23","volume-title":"Bisphosphonate mechanisms of action. Contemporary Endocrinology: Osteoporosis","author":"Reszka, A.A.","year":"2010","edition":"2"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1385\/BMM:1:1:03"},{"key":"atypb25","volume-title":"Metabolic bone disease","author":"Shoback, D.","year":"2007","edition":"8"},{"key":"atypb26","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0585"},{"key":"atypb27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp042806"},{"key":"atypb28","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2005.00327.x"},{"key":"atypb29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn038"},{"key":"atypb30","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0874"}],"container-title":["Therapeutic Advances in Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2042018810390260","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2042018810390260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:33:26Z","timestamp":1777592006000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2042018810390260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.1177\/2042018810390260"],"URL":"https:\/\/doi.org\/10.1177\/2042018810390260","relation":{},"ISSN":["2042-0188","2042-0196"],"issn-type":[{"value":"2042-0188","type":"print"},{"value":"2042-0196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}